Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Korosho to Talk with NCVC on Evaheart Issue
January 19, 2009
- Sales of Generics Top ¥10 Bil. at Meiji Seika
January 19, 2009
- Team of 16 Organizations Aims at Developing Artificial Joints Durable for 30 Years
January 19, 2009
- R&D of Micellar Anticancer Drugs Progresses at Nippon Kayaku
January 19, 2009
- Sato Pharm Launches Thyrogen to Aid in Thyroid Cancer Diagnosis
January 19, 2009
- Toho to Acquire Omwell
January 19, 2009
- SELF-MEDICATION NEWS IN BRIEF
January 19, 2009
- All Stakeholders' Cooperation Essential to Further Improve Distribution Business Practices: Mr Matsutani
January 19, 2009
- Why Seeds of Success Sprout from the Problem
January 19, 2009
- 52 Zensharen Hospitals Start Jointly Purchasing Drugs
January 19, 2009
- 4 Biologics Now Available in Japan for RA
January 19, 2009
- JPA to Watch Development in Niigata Prefecture
January 19, 2009
- Consider Expansion of Application of DRG/PPS: Council
January 19, 2009
- Create Market That Encourages Innovation: Mr Iwai of OPIR
January 19, 2009
- Give Patents to New Therapeutic Methods
January 19, 2009
- BUSINESS NEWS IN BRIEF
January 19, 2009
- Data on Tamiflu Should Be Published: Medwatcher Japan
January 19, 2009
- Sanjou General Hospital to Switch to In-House Prescriptions
January 19, 2009
- FY2009 Budget Proposal Includes ¥24,592 Bil. for Social Security
January 12, 2009
- Consumer, Patient Groups Present Questions to Rakuten
January 12, 2009
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…